New nanomanufacturing technique enhances vascular systems in artificial human tissue
When biomedical researchers need to test their latest ideas, they often turn to engineered human tissue that mimics…
Study reveals how gut fungi influence the brain’s dopamine response to alcohol
Researchers at Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences have found a surprising…
Yogi Adityanath Commends TMU’s Work on NEP and Startup Development During Courtesy Visit
Teerthanker Mahaveer University’s Founder Chancellor Suresh Jain paid a courtesy visit to Uttar Pradesh Chief Minister Yogi Adityanath.…
Experts call for action against imposter participants in health studies
Imposter participants threaten the integrity of health research and, by extension, the policies and clinical decisions built on…
Fatty acids found to be a primary driver of triple-negative tumor growth
A team from Huntsman Cancer Institute at the University of Utah (the U) has found that triple-negative breast…
New European trial tests subcutaneous EEG technology for people with epilepsy
A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is…
One in four U.S. hepatologists screen positive for unhealthy alcohol use
One in four hepatologists in the United States screened positive for unhealthy alcohol use in a survey study…
Blood test shows promise for faster ALS diagnosis
New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis…
UC Irvine develops human-like colon model for precision medicine
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to…
Low-dose steroids show promise for treating severe kidney inflammation
Will it be possible to treat severe kidney inflammation with fewer drugs in the future? A new study…
Could humans build floating cities on Venus?
The dream of living on another planet has intrigued scientists, engineers, and explorers for a long time. Now,…
SGLT-2 inhibitors offer protection against autoimmune conditions
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of…